近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Wang JH, Zhong XP, Zhang YF, Wu XL, Li SH, Jian PE, Ling YH, Shi M, Chen MS, Wei W, Guo RP. Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma. Cell death & disease. 2017 Sep 07;8(9):e3043. 2.Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang YF, Wang JH, Shi M, Wang HY, Guo RP. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Journal of cancer research and clinical oncology. 2017 Feb;143(2):263-73. 3.Zhong C, Zhang YF, Huang JH, Wang ZY, Chen QY, Su LT, Liu ZT, Xiong CM, Tao Z, Guo RP. The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade. American journal of translational research. 2017;9(6):2694-711. PubMed PMID: 28670362. 4.Li SH, Wang QX, Yang ZY, Jiang W, Li C, Sun P, Wei W, Shi M, Guo RP. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis. World journal of gastroenterology. 2017 May 7;23(17):3122-32. 5.Lu LH, Zhang YF, Wei W, Shi M, Guo RP. Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017 Aug 24. 6.Zhang YF, Zhou J, Wei W, Zou RH, Chen MS, Lau WY, Shi M, Guo RP. Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making. British journal of cancer. 2016 Oct 25;115(9):1039-47. 7.Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP. Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus. OncoTargets and therapy. 2016;9:4239-46. 8.Zhang YF, Le Y, Wei W, Zou RH, Wang JH, OuYang HY, Xiao CZ, Zhong XP, Shi M, Guo RP. Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis. Oncotarget. 2016 Jun 21;7(25):38845-56. 9.Zhang YF, Guo RP, Zou RH, Shen JX, Wei W, Li SH, OuYang HY, Zhu HB, Xu L, Lao XM, Shi M. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. European radiology. 2016 Jul;26(7):2078-88. 10.Zhang YF, Guo RP, OuYang HY, Shen JX, Zhao J, Tan GS, Le Y, Wei W, Shi M. Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization. Liver international : official journal of the International Association for the Study of the Liver. 2016 Oct;36(10):1516-24. 11.Wang, J.H., Wei, W., Xu, J., Guo, Z.X., Xiao, C.Z., Zhang, Y.F., Jian, P.E., Wu, X.L., Shi, M., Guo, R.P., Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma. Oncotarget 2015, 6(33), 35116-28. 12.Li Shaohua Wang Qiaoxuan Sun Peng Li Qing Yang Zhongyuan Shi Ming Wei Wei Guo Rongping. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis. PLOS ONE June 15, 2015 13.Zhong, C., Li, M.Y., Chen, Z.Y., Cheng, H.K., Hu, M.L., Ruan, Y.L., Guo, R.P., MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line. International journal of clinical and experimental pathology 2015, 8(9), 9922-31. 14.Zhang, Y.F., Wei, W., Guo, Z.X., Wang, J.H., Shi, M., Guo, R.P., Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus. Japanese journal of clinical oncology 2015, 45(9), 837-43. 15.Zhang, Y.F., Guo, R.P., Zou, R.H., Shen, J.X., Wei, W., Li, S.H., OuYang, H.Y., Zhu, H.B., Xu, L., Lao, X.M., Shi, M., Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. European radiology 2015. 16.Xiao, C.Z., Wei, W., Guo, Z.X., Li, S.H., Zhang, Y.F., Wang, J.H., Shi, M., Guo, R.P., A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection. Oncology letters 2015, 10(5), 2787-2794.. 17.Wang, J.H., Wei, W., Guo, Z.X., Shi, M., Guo, R.P., Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma. Journal of translational medicine 2015, 13, 41. 18.Zhong, C., Li, H.D., Liu, D.Y., Xu, F.B., Wu, J., Lin, X.M., Guo, R.P., Clinical study of hepatectomy combined with Jianpi Huayu Therapy for hepatocellular carcinoma. Asian Pacific journal of cancer prevention : APJCP 2014, 15(14), 5951-7.
京公网安备 11010802027423号